At Elemental Therapeutics, we're on a mission to restore the efficacy of antibiotics against drug-resistant infections. We’re developing a small molecule therapeutic, called PBT2, for treatment of community-acquired bacterial pneumonia (CABP). PBT2 is safe, low cost, orally bioavailable and has shown no development of resistance. Connect with us to help get PBT2 to the patients that need it and ensure antibiotics work first time, every time.
Elemental Therapeutics is a pre-incorporated preclinical stage biotechnology company. We are currently seeking investment for our preclinical development and mentors with commercial expertise.
Company Details
- Address
- University Of Melbourne, Melbourne,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Novel antibacterials, Small molecules, Antibiotic resistance, Drug discovery, Anti-infectives.
- HQ
- Melbourne
Elemental Therapeutics Questions
Elemental Therapeutics's website is https://www.elementaltherapeutics.com.au
Elemental Therapeutics's LinkedIn profile is https://au.linkedin.com/company/elemental-therapeutics-au
Elemental Therapeutics's industry is
Biotechnology Research
Elemental Therapeutics's top competitors are
Pelvify.com,
Abilityoptics,
Topicure,
Voltspec Pty Ltd,
Soundcell,
Mcdevitt Laboratory,
Put A Cup In It,
Elemental Therapeutics,
International Conference On Microneedles,
Csiro.
Elemental Therapeutics's categories are Biotechnology Research
